Parent Company and Investors

Neverblue is a wholly-owned, Canadian subsidiary of Vertrue Incorporated, which is a premier internet direct marketing services company. Vertrue operates a diverse group of marketing businesses that share a unified mission: to provide every consumer with access to savings and services that improve their daily lives. The company was founded in 1989 and became a publicly traded corporation in 1997. In fiscal year 2007, revenues reached approximately $800 million.

On March 22, 2007, Vertrue entered into a merger agreement with Velo Holdings Inc. and Velo Acquisition Inc. The transaction was completed on August 16, 2007. Vertrue's new ownership team includes Velo Holdings, a private investor group consisting of One Equity Partners, Rho Ventures and Brencourt Advisors, together with certain members of Vertrue's management.

One Equity Partners (OEP) makes private equity investments behind compelling business ideas and strong management teams. Established in 2001, OEP manages $8 billion of investments and commitments for JPMorgan Chase & Co. in direct private equity transactions. Partnering with management OEP invests in transactions that initiate strategic and operational changes in businesses to create long-term value. OEP's investment professionals are located across North America, Europe and Asia, with offices in New York, Europe, Menlo Park, Frankfurt and Hong Kong.

Rho Ventures, a division of Rho Capital Partners, has been backing emerging and high growth companies primarily in the U.S. since its inception in 1981. Venture capital and growth equity funds under management currently exceed $1.4 billion. Rho Ventures has invested in approximately 200 companies and helped build market leaders across many high growth industries. The firm is currently investing Rho Ventures V, a $425MM fund launched in 2005. Previous investments include Ciena Corporation, Compaq Computer (currently part of Hewlett Packard), Diversa, Human Genome Sciences, iVillage (currently part of NBC Universal), Leukosite (currently part of Millennium Pharmaceuticals), MedImmune, Senomyx, Silicon Graphics, Vanda Pharmaceuticals, Vicuron and Yantra (currently part of Sterling Commerce).